| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FDMT | 4D Molecular Therapeutics, Inc. | Bizily Scott | Chief Legal Officer | Apr 16, 2024 | Option Exercise | $16.67 | 3,500 | 58,340 | 3,487 | Apr 18, 2024, 08:48 PM | |
| FDMT | 4D Molecular Therapeutics, Inc. | Bizily Scott | Chief Legal Officer | Apr 01, 2024 | Option Exercise | $22.16 | 16,306 | 361,327 | 9,890 | Apr 03, 2024, 07:18 PM | |
| FDMT | 4D Molecular Therapeutics, Inc. | Bizily Scott | Chief Legal Officer | Mar 27, 2024 | Sale | $30.51 | 11,666 | 355,952 | 7,570 | Mar 29, 2024, 04:52 PM | |
| FDMT | 4D Molecular Therapeutics, Inc. | Bizily Scott | Chief Legal Officer | Mar 18, 2024 | Option Exercise | $19.43 | 3,500 | 68,018 | 3,487 | Mar 20, 2024, 04:40 PM | |
| FDMT | 4D Molecular Therapeutics, Inc. | Bizily Scott | Chief Legal Officer | Feb 27, 2024 | Option Exercise | $25.12 | 3,818 | 95,908 | 3,646 | Feb 29, 2024, 06:01 PM | |
| FDMT | 4D Molecular Therapeutics, Inc. | Bizily Scott | Chief Legal Officer | Feb 16, 2024 | Option Exercise | $17.63 | 3,500 | 61,717 | 3,487 | Feb 21, 2024, 05:41 PM | |
| FDMT | 4D Molecular Therapeutics, Inc. | Bizily Scott | Chief Legal Officer | Feb 08, 2024 | Option Exercise | $18.84 | 12,488 | 235,296 | 4,653 | Feb 12, 2024, 09:04 PM | |
| FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | Chief Executive Officer | Feb 08, 2024 | Sale | $27.13 | 92,001 | 2,495,822 | 1,059,153 | Feb 12, 2024, 08:22 PM | |
| FDMT | 4D Molecular Therapeutics, Inc. | Kim Robert Young | Chief Medical Officer | Feb 05, 2024 | Sale | $22.75 | 48,552 | 1,104,628 | 13,595 | Feb 07, 2024, 08:32 PM | |
| FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | Chief Executive Officer | Jan 23, 2024 | Sale | $18.41 | 5,696 | 104,851 | 1,151,154 | Jan 25, 2024, 04:59 PM | |
| FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | Chief Executive Officer | Dec 15, 2023 | Sale | $17.27 | 28,632 | 494,432 | 1,230,521 | Jan 08, 2024, 04:19 PM | |
| FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | Chief Executive Officer | Dec 18, 2023 | Sale | $18.13 | 4,702 | 85,243 | 1,225,819 | Jan 08, 2024, 04:19 PM | |
| FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | Chief Executive Officer | Jan 04, 2024 | Sale | $20.31 | 40,732 | 827,202 | 1,185,087 | Jan 08, 2024, 04:19 PM | |
| FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | Chief Executive Officer | Jan 05, 2024 | Sale | $19.57 | 28,237 | 552,478 | 1,156,983 | Jan 08, 2024, 04:19 PM | |
| FDMT | 4D Molecular Therapeutics, Inc. | Shabet Rose Sharon | 10% Owner | Jan 04, 2024 | Sale | $19.53 | 540,000 | 10,546,200 | 4,247,914 | Jan 05, 2024, 05:44 PM | |
| FMDT | 4D Molecular Therapeutics, Inc. | Bizily Scott | Chief Legal and HR Officer | Jun 08, 2023 | Sale | $14.45 | 7,500 | 108,338 | 5,487 | Jun 12, 2023, 06:23 PM | |
| FMDT | 4D Molecular Therapeutics, Inc. | Bizily Scott | Chief Legal and HR Officer | Jun 01, 2023 | Sale | $12.93 | 4,122 | 53,312 | 3,984 | Jun 06, 2023, 07:23 PM | |
| FMDT | 4D Molecular Therapeutics, Inc. | Moretti August J | Chief Financial Officer | May 15, 2023 | Option Exercise | $9.41 | 3,000 | 28,230 | 11,045 | May 16, 2023, 08:52 PM | |
| FDMT | 4D Molecular Therapeutics, Inc. | HALVORSEN OLE ANDREAS | 10% Owner | May 09, 2023 | Buy | $16.00 | 850,000 | 13,600,000 | 4,787,914 | May 11, 2023, 05:50 PM | |
| FDMT | 4D Molecular Therapeutics, Inc. | Bizily Scott | Chief Legal and HR Officer | Apr 21, 2023 | Sale | $14.02 | 7,500 | 105,150 | 5,859 | Apr 25, 2023, 06:44 PM | |
| FDMT | 4D Molecular Therapeutics, Inc. | Chacko Jacob | Director | Apr 21, 2023 | Sale | $14.73 | 10,000 | 147,319 | 5,000 | Apr 25, 2023, 06:43 PM | |
| FDMT | 4D Molecular Therapeutics, Inc. | Bizily Scott | Chief Legal and HR Officer | Mar 01, 2023 | Sale | $13.47 | 4,123 | 55,555 | 4,357 | Mar 03, 2023, 06:16 PM | |
| FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | Chief Executive Officer | Feb 21, 2023 | Sale | $20.96 | 17,997 | 377,209 | 1,876,509 | Feb 23, 2023, 07:56 PM | |
| FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | Chief Executive Officer | Feb 22, 2023 | Sale | $20.22 | 16,449 | 332,665 | 1,859,153 | Feb 23, 2023, 07:56 PM | |
| FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | Chief Executive Officer | Jan 19, 2023 | Sale | $20.03 | 10,899 | 218,347 | 1,902,224 | Jan 23, 2023, 07:57 PM | |
| FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | Chief Executive Officer | Jan 20, 2023 | Sale | $20.19 | 8,625 | 174,127 | 1,893,599 | Jan 23, 2023, 07:57 PM | |
| FDMT | 4D Molecular Therapeutics, Inc. | Moretti August J | Chief Financial Officer | Dec 21, 2022 | Option Exercise | $9.41 | 3,000 | 28,230 | 6,595 | Dec 22, 2022, 06:51 PM | |
| FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | Chief Executive Officer | Dec 15, 2022 | Sale | $23.59 | 32,933 | 776,767 | 1,968,567 | Dec 19, 2022, 05:56 PM | |
| FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | Chief Executive Officer | Dec 16, 2022 | Sale | $23.02 | 53,944 | 1,241,577 | 1,939,472 | Dec 19, 2022, 05:56 PM | |
| FDMT | 4D Molecular Therapeutics, Inc. | Bizily Scott | Chief Legal and HR Officer | Dec 01, 2022 | Sale | $15.40 | 11,625 | 179,044 | 6,607 | Dec 05, 2022, 05:33 PM | |
| FDMT | 4D Molecular Therapeutics Inc. | SCHAFFER DAVID | Director | Oct 22, 2021 | Sale | $31.00 | 1,900 | 58,893 | 901,215 | Oct 22, 2021, 09:42 PM | |
| FDMT | 4D Molecular Therapeutics Inc. | SCHAFFER DAVID | Director | Oct 20, 2021 | Sale | $31.02 | 11,565 | 358,771 | 925,935 | Oct 22, 2021, 09:42 PM | |
| FDMT | 4D Molecular Therapeutics Inc. | SCHAFFER DAVID | Director | Oct 21, 2021 | Sale | $31.56 | 22,820 | 720,156 | 903,115 | Oct 22, 2021, 09:42 PM | |
| FDMT | 4D Molecular Therapeutics Inc. | SCHAFFER DAVID | Director | Sep 29, 2021 | Sale | $28.61 | 16,871 | 482,614 | 958,950 | Oct 01, 2021, 04:34 PM | |
| FDMT | 4D Molecular Therapeutics Inc. | SCHAFFER DAVID | Director | Sep 30, 2021 | Sale | $26.91 | 12,385 | 333,250 | 942,049 | Oct 01, 2021, 04:34 PM | |
| FDMT | 4D Molecular Therapeutics Inc. | SCHAFFER DAVID | Director | Sep 28, 2021 | Sale | $30.53 | 13,912 | 424,693 | 966,856 | Sep 29, 2021, 04:05 PM | |
| FDMT | 4D Molecular Therapeutics Inc. | SCHAFFER DAVID | Director | Sep 27, 2021 | Sale | $32.89 | 19,332 | 635,826 | 986,925 | Sep 29, 2021, 04:05 PM | |
| FDMT | 4D Molecular Therapeutics Inc. | Moretti August J | Chief Financial Officer | Apr 12, 2021 | Option Exercise | $9.41 | 1,000 | 9,410 | 2,000 | Apr 14, 2021, 04:32 PM | |
| FDMT | 4D Molecular Therapeutics Inc. | Ott David C. | 10% Owner | Dec 15, 2020 | Buy | $23.00 | 1,100,000 | 25,300,000 | 3,937,914 | Dec 17, 2020, 09:15 PM | |
| FDMT | 4D Molecular Therapeutics Inc. | MILLIGAN JOHN F | Director | Dec 15, 2020 | Buy | $23.00 | 100,000 | 2,300,000 | 100,000 | Dec 17, 2020, 05:40 PM | |
| FDMT | 4D Molecular Therapeutics Inc. | Kamal Fariborz | See Remarks | Dec 15, 2020 | Buy | $23.00 | 4,347 | 99,981 | 4,347 | Dec 17, 2020, 05:40 PM | |
| FDMT | 4D Molecular Therapeutics Inc. | YAO TONY DUNG LING | Director | Dec 15, 2020 | Buy | $23.00 | 425,000 | 9,775,000 | 1,060,880 | Dec 17, 2020, 05:39 PM |
Menu